These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 20118033)

  • 1. Patient safety concerns for cognitively impaired patients with brain tumors.
    Doherty L; LaFrankie DC
    Clin J Oncol Nurs; 2010 Feb; 14(1):101-2. PubMed ID: 20118033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical management of brain tumor patients.
    Drappatz J; Schiff D; Kesari S; Norden AD; Wen PY
    Neurol Clin; 2007 Nov; 25(4):1035-71, ix. PubMed ID: 17964025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Impaired cognitive functioning in low-grade glioma patients: relationship to tumor localisation, radiotherapy and the use of anticonvulsants].
    Niël C
    Ned Tijdschr Geneeskd; 2005 Jan; 149(4):211-2; author reply 212. PubMed ID: 15702742
    [No Abstract]   [Full Text] [Related]  

  • 4. Cognitive functioning and quality of life in malignant glioma patients: a review of the literature.
    Weitzner MA; Meyers CA
    Psychooncology; 1997 Sep; 6(3):169-77. PubMed ID: 9313282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Impaired cognitive functioning in low-grade glioma patients: relationship to tumor localisation, radiotherapy and the use of anticonvulsants].
    Klein M; Heimans JJ; Aaronson NK; Postma TJ; Muller M; van der Ploeg HM; Taphoorn MJ
    Ned Tijdschr Geneeskd; 2004 Oct; 148(44):2175-80. PubMed ID: 15559412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of radiotherapy on cognitive function in patients with low-grade glioma measured by the folstein mini-mental state examination.
    Brown PD; Buckner JC; O'Fallon JR; Iturria NL; Brown CA; O'Neill BP; Scheithauer BW; Dinapoli RP; Arusell RM; Curran WJ; Abrams R; Shaw EG
    J Clin Oncol; 2003 Jul; 21(13):2519-24. PubMed ID: 12829670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The frequency of seizures in patients with primary brain tumors or cerebral metastases. An evaluation from the Ludwig Boltzmann Institute of Neuro-Oncology and the Department of Neurology, Kaiser Franz Josef Hospital, Vienna].
    Oberndorfer S; Schmal T; Lahrmann H; Urbanits S; Lindner K; Grisold W
    Wien Klin Wochenschr; 2002 Nov; 114(21-22):911-6. PubMed ID: 12528323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive deficits in adult patients with brain tumours.
    Taphoorn MJ; Klein M
    Lancet Neurol; 2004 Mar; 3(3):159-68. PubMed ID: 14980531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive functions and quality of life in patients with low-grade gliomas: the impact of radiotherapy.
    Taphoorn MJ; Schiphorst AK; Snoek FJ; Lindeboom J; Wolbers JG; Karim AB; Huijgens PC; Heimans JJ
    Ann Neurol; 1994 Jul; 36(1):48-54. PubMed ID: 8024261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical trial of MCNU for malignant brain tumors].
    Harada K; Okamoto H; Fujioka Y; Uozumi T; Kiya K; Kitaoka T; Goishi A; Sasaki U; Shima T; Inagawa T
    Gan To Kagaku Ryoho; 1985 Jul; 12(7):1423-31. PubMed ID: 2990350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detrimental effects of tumor progression on cognitive function of patients with high-grade glioma.
    Brown PD; Jensen AW; Felten SJ; Ballman KV; Schaefer PL; Jaeckle KA; Cerhan JH; Buckner JC
    J Clin Oncol; 2006 Dec; 24(34):5427-33. PubMed ID: 17135644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early detection and diagnosis of neurobehavioral disorders associated with cancer and its treatment.
    Meyers CA; Scheibel RS
    Oncology (Williston Park); 1990 Jul; 4(7):115-22; discussion 122, 126-7, 130. PubMed ID: 1697183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose escalation of carmustine in surgically implanted polymers in patients with recurrent malignant glioma: a New Approaches to Brain Tumor Therapy CNS Consortium trial.
    Olivi A; Grossman SA; Tatter S; Barker F; Judy K; Olsen J; Bruce J; Hilt D; Fisher J; Piantadosi S;
    J Clin Oncol; 2003 May; 21(9):1845-9. PubMed ID: 12721262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurocognitive sequelae of cancer treatment.
    Packer RJ; Mehta M
    Neurology; 2002 Jul; 59(1):8-10. PubMed ID: 12105300
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical patterns and biological correlates of cognitive dysfunction associated with cancer therapy.
    Dietrich J; Monje M; Wefel J; Meyers C
    Oncologist; 2008 Dec; 13(12):1285-95. PubMed ID: 19019972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive impairments associated with breast cancer treatments: results from a longitudinal study.
    Quesnel C; Savard J; Ivers H
    Breast Cancer Res Treat; 2009 Jul; 116(1):113-23. PubMed ID: 18629633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary brain tumors in adults.
    Chandana SR; Movva S; Arora M; Singh T
    Am Fam Physician; 2008 May; 77(10):1423-30. PubMed ID: 18533376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of the symptomatic management of malignant gliomas in adults.
    Shah U; Morrison T
    J Natl Compr Canc Netw; 2013 Apr; 11(4):424-9. PubMed ID: 23584345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New developments in the treatment of malignant gliomas.
    Soffietti R; Leoncini B; Rudà R
    Expert Rev Neurother; 2007 Oct; 7(10):1313-26. PubMed ID: 17939769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive rehabilitation in patients with gliomas: a randomized, controlled trial.
    Gehring K; Sitskoorn MM; Gundy CM; Sikkes SA; Klein M; Postma TJ; van den Bent MJ; Beute GN; Enting RH; Kappelle AC; Boogerd W; Veninga T; Twijnstra A; Boerman DH; Taphoorn MJ; Aaronson NK
    J Clin Oncol; 2009 Aug; 27(22):3712-22. PubMed ID: 19470928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.